Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.26 USD | +1.08% | -7.33% | +3.40% |
Mar. 01 | RBC Raises Price Target on Zynex to $15 From $13, Keeps Outperform Rating | MT |
Feb. 29 | Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024 | CI |
Business Summary
Number of employees: 1,100
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Related Supplies
68.1
%
| 115 | 72.5 % | 126 | 68.1 % | +9.44% |
Electrotherapy Devices
31.9
%
| 43 | 27.5 % | 59 | 31.9 % | +35.23% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
100.0
%
| 158 | 100.0 % | 184 | 100.0 % | +16.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Sandgaard
CEO | Chief Executive Officer | 65 | 95-12-31 |
Daniel Moorhead
DFI | Director of Finance/CFO | 51 | 17-06-04 |
Anna Lucsok
COO | Chief Operating Officer | 38 | 18-01-31 |
Steve Fox
SAM | Sales & Marketing | - | 19-12-31 |
Dave Anttila
HRO | Human Resources Officer | - | 18-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Barry Michaels
BRD | Director/Board Member | 74 | 18-01-09 |
Thomas Sandgaard
CEO | Chief Executive Officer | 65 | 95-12-31 |
Michael Cress
BRD | Director/Board Member | 66 | 18-01-09 |
Joshua Disbrow
BRD | Director/Board Member | 49 | 18-03-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,474,726 | 15,600,723 ( 38.54 %) | 8,545,044 ( 21.11 %) | 38.54 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.49% | 356M | |
+8.06% | 209B | |
+9.37% | 175B | |
+11.75% | 131B | |
+19.18% | 99.98B | |
-0.84% | 61.12B | |
+14.95% | 52.34B | |
-2.10% | 46.5B | |
+0.10% | 39.24B | |
+11.54% | 38.47B |
- Stock Market
- Equities
- ZYXI Stock
- Company Zynex, Inc.